๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Direct Oral Anticoagulants (DOACs)

DOAC in Chinese Patients With Atrial Fibrillation NCT05378035n/a1 site๐Ÿ“ Hong Kong Chinese University of Hong Kong ยท Tests: Blood Tests NOAC Therapy Guided by PARIS Risk Score and D-dimer in Patients With ACS After PCI NCT05638867Phase 41 site๐Ÿ“ Beijing China National Center for Cardiovascular Diseases ยท Tests: Aspirin + Clopidogrel + Rivaroxaban, Aspirin + Clopidogrel Advancing Knowledge in Ischemic Stroke Patients on Oral Anticoagulants NCT06823466n/a47 sites๐Ÿ“ Zagreb๐Ÿ“ Copenhagen๐Ÿ“ Asyut University of L'Aquila Oral Biopsy Bleeding in Patients on Direct Oral Anticoagulants (DOACs) NCT07520890n/a1 site๐Ÿ“ Pisa University of Pisa Safety and Efficacy of Intravenous Thrombolysis in Patients With Ischemic Stroke and Direct Oral Anticoagulants Intake NCT06571149Phase 4109 sites๐Ÿ“ Eisenstadt๐Ÿ“ Graz๐Ÿ“ Innsbruck Insel Gruppe AG, University Hospital Bern ยท Tests: Tenecteplase or Alteplase Direct Oral Anticoagulants (Rivaroxaban and Apixaban) in Patients With Liver Cirrhosis NCT04874428Phase 11 site๐Ÿ“ Bern Insel Gruppe AG, University Hospital Bern ยท Tests: Rivaroxaban 10 mg Oral Tablet, Apixaban 2.5 mg Oral Tablet Reduced-Dose Apixaban and Rivaroxaban Versus Low-Molecular-Weight Heparin in Patients With Hematologic Malignancies NCT07270263NA1 site๐Ÿ“ Gdansk Medical University of Gdansk ยท Tests: Apixaban, Rivaroxaban, low molecular weight heparin (enoxaparin sodium) Phase 3 Trial of Reltodecacog Alfa (VMX-C001) vs Usual Pharmacological Care in Patients Taking a FXa Direct Oral Anticoagulant Who Require Urgent Surgery With or Without Heparin. NCT07288489Phase 377 sites๐Ÿ“ Chandler๐Ÿ“ Phoenix๐Ÿ“ Phoenix VarmX B.V. ยท Tests: Reltodecacog alfa, Usual Pharmacological Care Clinical Performance Evaluation of Native Whole Blood Samples of Patients on DOACs With the Perosphere ClotChekโ„ข NCT07012291n/a4 sites๐Ÿ“ Danbury๐Ÿ“ Rockville๐Ÿ“ Denville Perosphere Technologies Inc. ยท Tests: Whole Blood Clotting Time, Whole Blood Clotting Time Thrombolysis in Factor Xa-inhibitors Trial NCT06878066Phase 321 sites๐Ÿ“ Aalborg๐Ÿ“ Aarhus๐Ÿ“ Baerum Guri Hagberg ยท Tests: thrombolysis therapy Cardiac Assessment for Recurrent Stroke Risk Evaluation in Atrial Fibrillation NCT06954610n/a1 site๐Ÿ“ Bern Insel Gruppe AG, University Hospital Bern ยท Tests: No intervention The Study of Monitoring and Dosing Guidance of Direct Oral Anticoagulants Based on Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics NCT06362343n/a1 site๐Ÿ“ Beijing Peking Union Medical College Hospital ยท Tests: Rivaroxaban Treatment Outcomes of Direct Oral Anticoagulants in Cerebral Venous Thrombosis in Vietnam NCT07083609n/a1 site๐Ÿ“ Hanoi Hieu Trung Dinh ยท Tests: Dabigatran, Rivaroxaban Avoiding Risks of Thrombosis and Bleeding in Surgery (ARTS) Trial NCT06523959Phase 41 site๐Ÿ“ Helsinki Clinical Urology and Epidemiology Working Group ยท Tests: Apixaban 2.5 MG Observational Study to Evaluate the Effectiveness of DOACS for Secondary Thrombosis Prevention in Low-risk Thrombotic APS Patients NCT07372170n/a2 sites๐Ÿ“ Madrid๐Ÿ“ Madrid Infanta Leonor University Hospital Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive Procedure NCT06957366NA14 sites๐Ÿ“ Hartford๐Ÿ“ Evanston๐Ÿ“ Boston McMaster University ยท Tests: PAUSE Perioperative DOAC Management, ASRA Perioperative DOAC Management RIVAroxaban Versus Low-molecular Weight Heparin in Patients With Lower Limb Trauma Requiring Brace or CASTing NCT06195540Phase 337 sites๐Ÿ“ Agen๐Ÿ“ Angers๐Ÿ“ Argenteuil University Hospital, Angers ยท Tests: Rivaroxaban 10 MG, Low Heparin Molecular Weight Cohort of Patients With Left Ventricular Thrombus: Management and Outcomes in the Direct Oral Anticoagulants Era NCT05028777n/a1 site๐Ÿ“ Bern Insel Gruppe AG, University Hospital Bern Intravenous Thrombolytic Therapy in Acute Ischemic Stroke Patients on DOAC NCT06241677NA1 site๐Ÿ“ Hong Kong Chinese University of Hong Kong ยท Tests: alteplase or tenecteplase Best Antithrombotic Therapy in Patients With Acute Venous ThromboEmbolism While Taking Antiplatelets NCT05627375Phase 328 sites๐Ÿ“ Amiens๐Ÿ“ Angers๐Ÿ“ Besanรงon Centre Hospitalier Universitaire de Saint Etienne ยท Tests: Full-dose anticoagulant therapy (AC), Antiplatelet therapy (AP) What is the Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation Undergoing PCI? NCT04436978Phase 420 sites๐Ÿ“ Aalst๐Ÿ“ Antwerp๐Ÿ“ Bonheiden St. Antonius Hospital ยท Tests: 30-day DAPT, Guideline-directed therapy Timing to Restart Direct Oral Anticoagulants After Traumatic Intracranial Haemorrhage NCT06322953Phase 32 sites๐Ÿ“ Plymouth๐Ÿ“ Liverpool Walton Centre NHS Foundation Trust ยท Tests: Direct-Acting Oral Anticoagulants (used as per local standard practice) Safety and Efficacy of Edoxaban and Rivaroxaban to Cerebral Venous Thrombosis in Chinese Patients NCT06947707n/a1 site๐Ÿ“ Beijing Xuanwu Hospital, Beijing Hip Fracture Surgery Timing and Blood Transfusion Risk in Patients on DOACs NCT07309848n/a7 sites๐Ÿ“ Almelo๐Ÿ“ Amsterdam๐Ÿ“ Arnhem St. Antonius Hospital Apixaban-PK Trial: Preventing Portal Hypertension Complications in Cirrhosis NCT07521332Phase 41 site๐Ÿ“ Hyderฤbฤd Asian Institute Of Medical Sciences ยท Tests: Apixaban, Carvedilol, Placebo Restarting Early Versus Later Anticoagulation for Chronic Subdural Hematoma With Atrial Fibrillation NCT06696079NA6 sites๐Ÿ“ Oulu๐Ÿ“ Kuopio๐Ÿ“ Tampere Rahul Raj ยท Tests: Early Resumption of Oral Anticoagulation Therapy, Late Resumption of Oral Anticoagulation Therapy Effect of Apiban Therapy on AVF Maturation in ESRD Patients NCT07559942NA1 site๐Ÿ“ Lahore Combined military hospital lahore ยท Tests: Apixaban Study Protocol: Impact of Metamizole (Optalginยฎ) on Anti-Xa Concentrations in Oncology Patients Receiving DOACs NCT07384013NA1 site๐Ÿ“ Haifa Rambam Health Care Campus ยท Tests: metamizole, metamizole The Direct Oral Anticoagulation Versus Vitamin K Antagonist After Cardiac Surgery Trial NCT04284839Phase 319 sites๐Ÿ“ Fitzroy๐Ÿ“ Parkville๐Ÿ“ Edmonton Population Health Research Institute ยท Tests: DOAC, VKA The Association Between Non-vitamin K Antagonist Oral Anticoagulant Concentration and Clinical Outcomes. NCT05333666n/a2 sites๐Ÿ“ Taipei๐Ÿ“ Taipei National Taiwan University Hospital ยท Tests: Data collection
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy